Invesco Advisers has agreed to pay $17.5 million to settle charges from the U.S. Securities and Exchange Commission (SEC) regarding misleading statements about the extent to which its assets incorporated environmental, social, and governance (ESG) factors in its investment decisions. Meanwhile, Elanco Animal Health will pay a $15 million civil fine to resolve SEC anti-fraud charges. The SEC found that Elanco misled investors concerning its revenue growth and end-user demand. These settlements highlight ongoing regulatory scrutiny over transparency and accuracy in financial disclosures by investment firms and corporations.
Elanco Animal Health agreed to pay a $15 million civil fine to settle U.S. Securities and Exchange Commission anti-fraud charges for misleading investors about its revenue growth and end-user demand, the regulator said on Tuesday. https://t.co/Gem1HL0JJW https://t.co/Gem1HL0JJW
SEC Fines Elanco $15 Million Over Sales Incentive Practices https://t.co/y5rdo5Q3OS
Elanco Animal Health agreed to pay a $15 million civil fine to settle SEC anti-fraud charges for misleading investors about its revenue growth and end-user demand, the regulator said https://t.co/9Mw7cTdYkB https://t.co/e7zmvfezPX